Next Generation News and Research

RSS

Samplify receives second series of patent for medical imaging applications

Samplify Systems, Inc., a leading provider of signal-compression technology, semiconductors, and solutions, today announced that the Chinese Government has granted the company its second series of technology patents for medical imaging applications. These new patents come on the heels of the first series of patents that were granted earlier this month for wireless base station compression.

23 Aug 2010

Experts explore factors contributing to global nurse faculty migration

Twenty-one experts from 12 countries convened near Geneva, Switzerland, in late June to explore current patterns, types, and causal and contributing factors of global nurse faculty migration, a phenomenon where nursing faculty leave their country of origin to work elsewhere.

21 Aug 2010

Angeion partners with Data Innovations to create MedGraphics BreezeConnect software interface

Angeion Corporation today announced that it has partnered with Data Innovations to create MedGraphics BreezeConnect, a software interface that provides interfacing options in one comprehensive solution. BreezeConnect is currently available in the United States and is expected to launch internationally in September.

21 Aug 2010

Bavarian Nordic comments on Obama Administration's revised strategy for medical countermeasures

Bavarian Nordic A/S -- a leading industrial biotechnology company and long-term collaborator with the U.S. Government on the development of vaccines for the protection against biological threats, today commented on the Obama Administration's revised strategy for development, procurement and stockpiling of medical countermeasures.

20 Aug 2010

Statoil ASA launches new ear plug to alleviate noise-induced hearing impairment

Some 600 cases of noise-induced hearing impairment are reported by the Norwegian petroleum industry every year. A new, intelligent earplug is now set to alleviate the problem.

20 Aug 2010

USPTO rules out Oculir's claim on noninvasive glucose measuring device patent

The U.S. Patent and Trademark Office (USPTO) has held that all claims in Oculir's Patent No. 6,958,039 to be invalid as not patentable based on prior art from a patent disclosure by Yale researcher, Dr. Marc Abreu.

20 Aug 2010

Montana State University offers new biomedical technologies for prevention, treatment of viral infections

Researchers at Montana State University have developed six new biomedical technologies that could have applications for treating antibiotic resistant infections, fungal infections and viral infections; boosting humans' innate immunity and improving scientists' ability to study such compounds. The technologies are available for licensing to interested companies and entrepreneurs.

19 Aug 2010

Varian to showcase new Gated RapidArc technology at 2010 CHINA-HOSPEQ exhibition

Varian Medical Systems, Inc. will showcase the company's new Gated RapidArc technology on its Trilogy® machine with advanced motion management capabilities at the 2010 CHINA-HOSPEQ exhibition being held in Beijing August 19-21 by China's Ministry of Health. Varian, the world's leading manufacturer of medical technology for treating cancer and a premier supplier of X-ray imaging technology, will also exhibit its software for planning and for managing radiation therapy treatments.

18 Aug 2010

Medtronic to acquire Osteotech for $6.50 per share

Medtronic Inc.,and Osteotech, Inc.,today announced that the companies have signed a definitive agreement under which Medtronic will acquire Osteotech for $6.50 per share in cash for each share of Osteotech common stock. The total value of the transaction is expected to be approximately $123 million.

18 Aug 2010

Chronix Biomedical expands biomarker development capabilities with installation of DNA mass sequencer

Chronix Biomedical today reported that it has significantly expanded and accelerated its biomarker development capabilities with the installation of Germany's first state-of-the-art high-throughput DNA mass sequencer at the University of Göttingen, Chronix's long-time collaborator. Chronix is developing disease-specific biomarkers based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells.

17 Aug 2010

IVAX Diagnostics second quarter 2010 operating expenses decrease 11.9%

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, reports its financial results for the quarter ended June 30, 2010.

17 Aug 2010

Alverix and BD partner to develop point of care infectious disease diagnostic assay systems

As consumers begin to take greater ownership of their own healthcare, there is a growing demand for accessibility to diagnostic testing. Alverix, Inc. and BD (Becton, Dickinson and Company) are on the cutting edge of this trend and today announced an agreement to produce assay systems at the point-of-care (POC) that will improve infectious disease diagnoses.

From BD (Becton, Dickinson and Company) 16 Aug 2010

Massachusetts General Hospital implants Levacor Ventricular Assist Device

World Heart Corporation, a developer of mechanical circulatory systems, announced today that the Massachusetts General Hospital in Boston, Mass. has successfully implanted its first Levacor™ Ventricular Assist Device (VAD). Mass General is the fifth implanting site nationwide in the Levacor VAD Bridge-to-Transplant (BTT) Study. This is the eleventh implant with the Levacor VAD since the inception of the BTT study.

16 Aug 2010

Medforma unveils new Internet-based wellness platform

Nearly 80 percent of health care costs are spent on treating preventable diseases. And most of this burden falls on employers and employees. To help employers reduce these expenses while improving the health of their workforces, St. Paul-based Medforma Inc., today unveiled the next-generation of its Internet-based wellness platform called Health Portrait™.

16 Aug 2010

Cox Business light-speed computer accelerates TGen’s molecular research

A Cox Business light-speed computer connection coupled with advanced, military-grade technology now provides Translational Genomics Research Institute (TGen) with the nation's fastest supercomputer link among life-sciences facilities.

16 Aug 2010

Cox Business light-speed computer connection provides TGen with fastest supercomputer link

A Cox Business light-speed computer connection coupled with advanced, military-grade technology now provides Translational Genomics Research Institute with the nation's fastest supercomputer link among life-sciences facilities.

13 Aug 2010

Quick-Med Technologies, Biosara sign development agreement

Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that it has signed a development agreement with Biosara Corporation, a medical device company targeting wound dressings for major medical and healthcare providers, along with the multi-billion dollar organized sports athlete markets.

13 Aug 2010

Benvenue Medical commences treatment in U.S. with Blazer Vertebral Augmentation System

Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced today that it has treated the first patient in the United States with the Blazer Vertebral Augmentation System - a new device for the treatment of vertebral compression fractures (VCFs). The case was performed by Francis Facchini, M.D., partner, VIR Chicago, at Adventist GlenOaks Hospital in Glendale Heights, Illinois.

13 Aug 2010

Guided Therapeutics second-quarter service revenue increases to $0.8 million

Guided Therapeutics, Inc. today announced its operating results for the second quarter and first six months of 2010.

13 Aug 2010

Astex and MMRC commence Phase II clinical trial of AT7519 CDK inhibitor in multiple myeloma

Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, and the Multiple Myeloma Research Consortium announced today the initiation of a Phase II clinical trial of the cyclin-dependent kinase inhibitor, AT7519, to treat patients with relapsed or refractory multiple myeloma, an incurable blood cancer. The trial is designed to investigate both single agent and combination activity of AT7519 with bortezomib (Velcade®).

13 Aug 2010

Next Generation News and Research

Samplify receives second series of patent for medical imaging applications

Experts explore factors contributing to global nurse faculty migration

Angeion partners with Data Innovations to create MedGraphics BreezeConnect software interface

Bavarian Nordic comments on Obama Administration's revised strategy for medical countermeasures

Statoil ASA launches new ear plug to alleviate noise-induced hearing impairment

USPTO rules out Oculir's claim on noninvasive glucose measuring device patent

Montana State University offers new biomedical technologies for prevention, treatment of viral infections

Varian to showcase new Gated RapidArc technology at 2010 CHINA-HOSPEQ exhibition

Medtronic to acquire Osteotech for $6.50 per share

Chronix Biomedical expands biomarker development capabilities with installation of DNA mass sequencer

IVAX Diagnostics second quarter 2010 operating expenses decrease 11.9%

Alverix and BD partner to develop point of care infectious disease diagnostic assay systems

Massachusetts General Hospital implants Levacor Ventricular Assist Device

Medforma unveils new Internet-based wellness platform

Cox Business light-speed computer accelerates TGen’s molecular research

Cox Business light-speed computer connection provides TGen with fastest supercomputer link

Quick-Med Technologies, Biosara sign development agreement

Benvenue Medical commences treatment in U.S. with Blazer Vertebral Augmentation System

Guided Therapeutics second-quarter service revenue increases to $0.8 million

Astex and MMRC commence Phase II clinical trial of AT7519 CDK inhibitor in multiple myeloma

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News